Increased serum asymmetric dimethylarginine levels in primary dysmenorrhea

Gynecologic and Obstetric Investigation

Volumn 69, Issue 3, 2010, Pages 153-156

  Akdemir, Nermin ^a   Cinemre, Hakan ^c   Bilir, Cemil ^c   Akin, Okhan ^a   Akdemir, Ramazan ^b  

^a Kecioren Education and Research Hospital   (Turkey)

^b Diskapi Education and Research Hospital   (Turkey)

^c DUZCE UNIVERSITY   (Turkey)

Author keywords

Asymmetric dimethylarginine; Endothelial dysfunction; Primary dysmenorrhea

Indexed keywords

C REACTIVE PROTEIN; CA 125 ANTIGEN; ESTRADIOL; FOLLITROPIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LUTEINIZING HORMONE; N(G),N(G) DIMETHYLARGININE; THYROTROPIN; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; AMINO ACID BLOOD LEVEL; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DYSMENORRHEA; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HORMONE BLOOD LEVEL; HUMAN; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ARGININE; BIOLOGICAL MARKERS; BODY MASS INDEX; C-REACTIVE PROTEIN; CHOLESTEROL, LDL; COHORT STUDIES; DYSMENORRHEA; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; ISCHEMIA; NITRIC OXIDE; PELVIC PAIN; SENSITIVITY AND SPECIFICITY; TRIGLYCERIDES; UTERUS; YOUNG ADULT;

EID: 71249158563     PISSN: 03787346     EISSN: None     Source Type: Journal    
DOI: 10.1159/000264671     Document Type: Article

References (21)

1. Dawood MY: Primary dysmenorrhea: advances in pathogenesis and management. Obstet Gynecol 2006; 108: 428-441.
2. Burnett MA, Antao V, Black A, Feldman K, Grenville A, Lea R, et al: Prevalence of primary dysmenorrhea in Canada. J Obstet Gynaecol Can 2005; 27: 765-770.
3. Jabbour HN, Sales KJ, Smith OP, et al: Prostaglandin receptors are mediators of vascular function in endometrial pathologies. Mol Cell Endocrinol 2006; 252: 191-200.
4. French L: Dysmenorrhea. Am Fam Physician 2005; 71: 285-291.
5. Siekmeier R, Grammer T, März W: Roles of oxidants, nitric oxide, and asymmetric dimethylarginine in endothelial function. J Cardiovasc Pharmacol Ther 2008; 13: 279-297.
6. Kielstein JT, Böger RH, Bode-Böger SM, Schäffer J, Barbey M, Koch KM, Frölich JC: Asymmetric dimethylarginine plasma concentrations differ in patients with end-stage renal disease: relationship to treatment method and atherosclerotic disease. J Am Soc Nephrol 1999; 10: 594-600.
7. Kielstein JT, Böger RH, Bode-Böger SM, Frölich JC, Haller H, Ritz E, Fliser D: Marked increase of asymmetric dimethylarginine in patients with incipient primary chronic renal disease. J Am Soc Nephrol 2002; 13: 170-176.
8. Kielstein JT, Bode-Boger SM, Hesse G, Martens-Lobenhoffer J, Takacs A, Fliser D, Hoeper M: Asymmetric dimethylarginine in idiopathic pulmonary hypertension. Atheroscler Thromb Vasc Biol 2005; 25: 1-5.
9. Kielstein JT, Donnerstag F, Gasper S, Menne J, Kielstein A, Martens-Lobenhoffer J, Scalera F, Cooke JP, Fliser D, Bode-Böger SM: ADMA increases arterial stiffness and decreases cerebral blood flow in human. Stroke 2006; 37: 2024-2029.
10. Dawood MY: Current concepts in the etiology and treatment of primary dysmenorrhea. Acta Obstet Gynecol Scand Suppl 1986; 138: 7-10.
11. Doty E, Attaran M: Managing primary dysmenorrhea. J Pediatr Adolesc Gynecol 2006; 19: 341-344.
12. Duarin D: Primary dysmenorrhea: assessment and management update. J Midwifery Womens Health 2004; 49: 520-528.
13. Liedman R, Skillern L, James I, et al: Validation of a test model of induced dysmenorrhea. Acta Obstet Gynecol Scand 2006; 85: 451-457.
14. Valentin L, Sladkevicius P, Kindahl H, Broeders A, Marsal K, Melin P: Effects of a vasopressin antagonist in women with dysmenorrhea. Gynecol Obstet Invest 2000; 50: 170-177.
15. Scalera F, Kielstein JT, Martens-Lobenhoffer J, Postel SC, Täger M, Bode-Böger SM: Erythropoietin increases asymmetric dimethylarginine in endothelial cells: role of dimethylarginine dimethylaminohydrolase. J Am Soc Nephrol 2005; 16: 892-898.
16. Cameron IT, Campbell S: Nitric oxide in the endometrium. Hum Reprod Update 1998; 4: 565-569.
17. Chwalisz K, Garfield RE: Role of nitric oxide in implantation and menstruation. Hum Reprod 2000; 15(suppl 3):96-111.
18. Transdermal nitroglycerine in the management of pain associated with primary dysmenorrhoea: a multinational pilot study. The Transdermal Nitroglycerine/Dysmenorrhoea Study Group. J Int Med Res 1997; 25: 41-44.
19. Moya RA, Moisa CF, Morales F, Wynter H, Ali A, Narancio E: Transdermal glyceryl trinitrate in the management of primary dysmenorrhea. Int J Gynaecol Obstet 2000; 69: 113-118.
20. Facchinetti F, Sgarbi L, Piccinini F, Volpe A: A comparison of glyceryl trinitrate with diclofenac for the treatment of primary dysmenorrhea: an open, randomized, crossover trial. J Obstet Gynaecol Can 2005; 27: 765-770.
21. Böger RH, Bode-Böger SM, Szuba A, Tsao PS, Chan JR, Tangphao O, Blaschke TF, Cooke JP: Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. Circulation 1998; 98: 1842-1847.